ArticleCancer research and treatment2017
Comparison of Clinical Outcomes of
Article in Cancer research and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer.Journal of breast cancer · 2026Article
- Multigene germline and somatic testing for epithelial ovarian cancer in China.NPJ precision oncology · 2025Article
- Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.Genes, chromosomes & cancer · 2023Review
- Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma.Cancers · 2023Article
- Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis.Cancers · 2022Article
- Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.International journal of molecular sciences · 2022Article
- Recurrent Ovarian Cancer with BRCAness Phenotype: A Treatment Challenge.Advances in therapy · 2022Article
- Current update on malignant epithelial ovarian tumors.Abdominal radiology (New York) · 2021Review
- Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.Journal of Cancer · 2021Review
- Reclassification ofJournal of gynecologic oncology · 2020Article
- Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.BMC cancer · 2020Article
- Prevalence and oncologic outcomes ofObstetrics & gynecology science · 2019Article
- Clinical significance of variants of unknown significances inJournal of gynecologic oncology · 2019Article
- Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review.Cancer research and treatment · 2019Review
- Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.Journal of ovarian research · 2019Article
- Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts.Scientific reports · 2019Article
- The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2018Article
- Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.Cancer research and treatment · 2018Article
- Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.Journal of gynecologic oncology · 2018Article
- Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.Journal of gynecologic oncology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to investigate the clinical features of epithelial ovarian cancer (EOC) patients according to MATERIALS AND
methodsWe analyzed 116 patients whose
resultsThirty-seven (37/116, 31.9%)
conclusionPatientswith
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.